Articles

Find an Article

Filter articles

Applied Filters

Showing 121 to 130 of 136 results

A changing landscape: life sciences in Russia

01-05-2012Maria Nilova and Vadim Chagin

Russia’s life sciences industry is growing rapidly, say Vadim Chagin and Maria Nilova.

A step into the unknown: India's first compulsory licence

01-05-2012Archana Shanker

For the first time in the history of the Indian patent system, a compulsory licence has been granted. Archana Shanker considers the implications.

For better, for worse? How shifting IP laws change the global life sciences regulatory chessboard

01-05-2011

With IP laws around the world subject to frequent and sometimes unpredictable changes, it can be difficult to keep abreast of everything you need to know. Richard Gough and Jane Woodhouse take a look.

It’s good to litigate a patent or two

01-05-2011

Europe is home to many life sciences companies, so IP regimes throughout the continent’s jurisdictions need to provide cost-effective, speedy and certain litigation environments if patent disputes are to be satisfactorily settled.

Building operative partnerships with law enforcement

01-05-2011Vaughn Volpi

There is a perfect storm brewing in the healthcare industry. Over the past few years, there has been an unprecedented rise in the trade of illicit healthcare products in the secondary market.

Practice points in Israel patent prosecution: selection patents and treatment of earlier-filed patent applications

Israel01-05-2011Moshe Tritel

Israel patent practice is distinct from US and European practice in a number of respects. Moshe Tritel describes a number of such areas with important practical ramifications for applicants seeking to maximise their patent protection in Israel.

Clinical trials in BioPharma

US01-05-2011Eric Steffe

A recent study revealed that biotechnology companies or universities discovered 42 percent of all innovative drugs approved by the US Food and Drug Administration (FDA) between 1998 and 2007.

Clinical trials and stratified medicine—maximising patent exclusivity

01-05-2011Richard Korn and Stephanie Pilkington

The traditional business model for a new drug relies on a substantial period of market exclusivity to recoup extensive research and development costs.

Traditional medicine patents lead to enhanced drug discovery from natural products

01-05-2011John Zabilski

Natural products have been used to relieve a variety of diseases and conditions for millennia.

US Patent Law changes appear imminent

US01-05-2011John Pegram and Mark Ellinger

US patent reform looks like it may finally be coming. John Pegram and Mark Ellinger explain the proposed changes.

Showing 121 to 130 of 136 results

LSIPR